KUWAIT: Just afew days before one of the world's largest health and medical conferences -Arab Health - took place, Kuwait scored an important medical milestone with thefirst cardiac ablation treatment done in the private sector. Cardiac ablationis a complex cardiac procedure used to treat abnormal electrical activity inthe heart.
Given the complexnature of the treatment, cardiac ablation is usually done by only a handful oftrained cardiologists in Kuwait's public sector hospitals. But thanks to acollaboration between Kuwait's Central Circle medical company and Johnson &Johnson Middle East, the cutting-edge treatment is now available in the privatehealthcare sector in Kuwait.
A team of leadingdoctors including electrophysiologist Dr Fawzia Alkandari performed thegroundbreaking and complex procedure at Hadi Hospital. The event is a majorleap in the right direction in acknowledging the importance of such treatments,which shouldn't be held from patients in need. The cardiac ablation was coveredby insurance. Johnson & Johnson is a top manufacturer of the ablationtechnology. They have partnered with Central Circle in Kuwait to bring thisinnovative treatment to the private sector.
"A vitaltreatment such as ablation therapy should be made accessible to all those whoneed it," stated Dr Ziad Al-Alyan, Central Circle CEO. Dr Al-Alyan thankedthe great Johnson & Johnson team and the team at Hadi Hospital for makingthe groundbreaking treatment become a reality. Cardiac arrhythmia is relativelycommon in Kuwait due to the high prevalence of heart disease in the region.Having the private sector contribute in the treatment availability reduces waittimes for patients and results in better outcomes for public health in general.